Looking for volunteers
Clinical Trial of Approaches to Prostate Cancer Surgery
NCT05155501 · Weill Medical College of Cornell University · Updated 22 April 2026
- What is being tested
- Robot-assisted radical prostatectomy (RP); Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 40 years to 80 years. About 600 people. The full rules are on the registry page.
- Where
- United States (9 sites)
- When
- Starts or started 15 May 2023, ends July 2028. Registered 13 Dec 2021.
- Results
- None posted yet.
In the researchers' words
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Sites
- Beckman Research Institute of City of HopeDuarte, California, United States
- Georgetown UniversityWashington D.C., District of Columbia, United States
- Northwestern UniversityChicago, Illinois, United States
- Johns Hopkins UniversityBaltimore, Maryland, United States
- Beth Israel Deaconess Medical Center (BIDMC)Boston, Massachusetts, United States
- Hackensack Meridian HealthHackensack, New Jersey, United States
- NewYork-Presbyterian QueensFlushing, New York, United States
- Memorial Sloan Kettering Cancer CenterNew York, New York, United States
- Weill Cornell MedicineNew York, New York, United States